REVIVE-CAP - Risk-guidEd preVentIon of long-term cardioVascular sEquelae after Community-Acquired Pneumonia (GA n. 101344053)

The REVIVE-CAP project will last 4 years and aims to improve the prevention, diagnosis and management of long-term cardiovascular sequelae following community-acquired pneumonia (CAP). The research activities will include the characterization of post-CAP cardiovascular sequelae across different European countries; the early identification of high-risk patients; the development and validation of an artificial intelligence (AI)-based tool for cardiovascular risk prediction